The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT04431726
Brief Title:	A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors (HAVEN 7)

First Submitted :	June 11, 2020
First Submitted that Met QC Criteria :	June 11, 2020
First Posted :	June 16, 2020

Last Update Submitted that Met QC Criteria :	February 12, 2024
Last Update Posted :	February 13, 2024

To Top